A 23-year-old man was initiated on acamprosate 666mg in the morning. He developed sedation and emesis [ time to reaction onset not stated ] and his dosage was reduced to 333 mg/day. His symptoms improved and he continued acamprosate for 16 weeks. COMMENT Editorial Comment : A search of ...
DosageAvailable as acamprosate calcium; dosage expressed in terms of the salt.AdultsAlcohol DependenceMaintenance of Abstinence of Alcohol Ingestion Oral 666 mg 3 times daily.A lower dosage (1.3 grams daily given in 3 unequally divided doses of 666, 333, and 333 mg) also evaluated in clinical...
How is acamprosate supplied (dosage forms)? Acamprosate is available as 333 mg delayed-release oral tablets that are taken by mouth. How should I store acamprosate? Acamprosate should be stored at room temperature, between 68 F to 77 F (20 C to 25 C). It can be exposed to temperatures ...
It is available as a 333 mg tablet, and the recommended dosage regimen is two 333 mg tablets taken three times a day which may be prescribed in a blistercard. Clinical trials have typically shown that acamprosate is effective in maintaining abstinence in recently detoxified patients, especially ...
Acamprosate is contraindicated in patients with a known hypersensitivity to the drug, in pregnant or lactating women, in patients with renal impairment (serum creatinine >0.12 mmol/L), in patients with severe hepatic failure (Pugh grade C), in children and in the elderly. Specific dosage recommen...
To study the pharmacokinetics of acamprosate calcium (CAS 77337-73-6) in healthy Chinese subjects after oral administration of three dosage levels, 12 healthy subjects were divided into three groups and given a single oral dose of 333 or 666 or 1332 mg acamprosate calcium (enteric coated tablet...
PharmacokineticsPharmacokinetic data of acamprosate tablets was not accessible on large number of human. Rationale to examine the pharmacokinetic properties of acamprosate calcium in healthy male subject, on single or multiple dosage administration, to evaluate the bioequivalence of two formulations of ...